draggable-hero color-white g-font

Forwardly is a public company seeking opportunities to partner in fresh ideas.

fresh forwardly approach to value investing

Forwardly is an opportunity investor seeking to finance fresh ideas. The company is headed by George Sharp, a longtime whistleblower and advocate against microcap fraud.

In addition to consulting to public companies, attorneys and those associated with the financial markets, Mr. Sharp is a former consultant to OTC Markets Group, Inc.

George Sharp, President and CEO of Forwardly, Inc. (OTCMKT: FORW), announced today that the company has made a strategic investment in Maverick Energy Group, Inc. (OTCMKT: MKGP). 

“The kicker for us was the ability to acquire the warrants which could not only be a source of continued funding for Maverick but makes us a low risk investor. The incredible success of our past warrant acquisitions has given Forwardly an incredible appetite for opportunities such as this.

George Sharp | President • CEO (April 15, 2021)

Maverick Energy Website

hs-fullwidth bg-dark color-white

Latest News

October 13, 2021

Forwardly’s Ligand Innovation Global Completes Production of First LifeAir G1 Prototypes

Mississauga, ON and Henderson, NV, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Dr. Dayo Olakulehin, CEO of Ligand Innovation Global, Inc., (“Ligand”) a partially owned company and partner of Forwardly, Inc. (OTCMKT: FORW), announced today that Ligand has produced two working units of the latest iteration of the LifeAir G1 Portable Ventilator. Upon completion of the production of four additional prototypes, expectedly within the next two weeks, the LifeAir G1 will be fully commissioned.

Full Press Release

August 25, 2021

Forwardly’s Ligand Innovation Global Receives Significant Designations Under the Patent Cooperation Treaty

Mississauga, ON and Henderson, NV, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Dr. Dayo Olakulehin, CEO of Ligand Innovation Global, Inc., (“Ligand”) a partially owned company and partner of Forwardly, Inc. (OTCMKT: FORW), announced today that Ligand has received important designations under the Patent Cooperation Treaty (“PCT”).

Full Press Release

Projects • Investments

a wholly owned subsidiary of Forwardly, Inc.

Evolutionary. Revolutionary.

LifeAir™ G1 ventilator prototype.

"Medical Innovation is not just about entrepreneurship, but is also an amazing avenue to save lives and give hope." - Ligand Innovation Global.

LifeAir™ – G1 Ventilator

The LifeAir G1 is a ventilator designed to automate cardiopulmonary resuscitation bags to deliver controlled breaths to patients who have difficulty breathing. Unlike conventional ventilators, the LifeAir is affordable, easy to use, portable – powered by batteries and rechargeable. Conventional ventilators commonly used in intensive care units (ICU) cost $30,000. The LIfeAir will be offered in the low thousands, and is an innovative solution to a severe problem that has truncated the lives of many.

Learn more